{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:21:56Z","timestamp":1769106116002,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e27291","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T11:55:33Z","timestamp":1709639733000},"page":"e27291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-4352","authenticated-orcid":false,"given":"Murat","family":"Keskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3440-1940","authenticated-orcid":false,"given":"Sercan","family":"Avul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-8016","authenticated-orcid":false,"given":"Aylin","family":"Beyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1457-4366","authenticated-orcid":false,"given":"Nizameddin","family":"Koca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27291_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jfma.2019.03.014","article-title":"Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis","volume":"119","author":"Huang","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/ceh.2018.78120","article-title":"A systematic review of the present and future of non-alcoholic fatty liver disease","volume":"4","author":"Lucas","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e27291_bib6","series-title":"Epidemiological Investigation of Nonalcoholic Fatty Liver in Residents of Karamaycityin Xinjiang","author":"Xw","year":"2012"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e27291_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010021","article-title":"Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.heliyon.2024.e27291_bib8","doi-asserted-by":"crossref","DOI":"10.14744\/hf.2023.2023.0044","article-title":"The heated debate over NAFLD renaming: an ongoing saga","author":"Y\u0131lmaz","year":"2023","journal-title":"Hepatology Forum"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/bbrc.2001.5945","article-title":"A role for neuromedin U in stress response","volume":"289","author":"Hanada","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27291_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm1106","article-title":"Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway","volume":"10","author":"Hanada","year":"2004","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbrc.2003.10.098","article-title":"Central actions of neuromedin U via corticotropin-releasing hormone","volume":"311","author":"Hanada","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6791","key":"10.1016\/j.heliyon.2024.e27291_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/35017610","article-title":"Identification of receptors for neuromedin U and its role in feeding","volume":"406","author":"Howard","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/bbrc.2000.3502","article-title":"Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3)","volume":"276","author":"Kojima","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20050248","article-title":"The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells","volume":"202","author":"Moriyama","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2004.04.014","article-title":"The gut\u2013brain peptide neuromedin U is involved in the mammalian circadian oscillator system","volume":"318","author":"Nakahara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/bbrc.2000.3669","article-title":"Central effects of neuromedin U in the regulation of energy homeostasis","volume":"277","author":"Nakazato","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27291_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084238","article-title":"Neuromedin U, a key molecule in metabolic disorders","volume":"22","author":"Teranishi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27291_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.peptides.2017.09.011","article-title":"Role of neuromedin U in accelerating of non-alcoholic steatohepatitis in mice","volume":"99","author":"Teranishi","year":"2018","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27291_bib19","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1210\/en.2002-220121","article-title":"Evaluation of neuromedin U actions in energy homeostasis and pituitary function","volume":"143","author":"Ivanov","year":"2002","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib20","doi-asserted-by":"crossref","first-page":"E301","DOI":"10.1152\/ajpendo.00404.2004","article-title":"Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin","volume":"289","author":"Jethwa","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2013.07.012","article-title":"Drug-induced steatohepatitis","volume":"17","author":"Patel","year":"2013","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27291_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00365521.2014.881548","article-title":"Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy","volume":"49","author":"Yilmaz","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","article-title":"Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease","volume":"54","author":"Zein","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-28032012000100015","article-title":"Metabolic syndrome and risk factors for non-alcoholic fatty liver disease","volume":"49","author":"Souza","year":"2012","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e27291_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1015919","article-title":"Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score","volume":"11","author":"Jang","year":"2023","journal-title":"Front. Public Health"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e27291_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006381","article-title":"Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib29","first-page":"1","article-title":"Obesity, age, ethnicity, and clinical features of prostate cancer patients","volume":"5","author":"Wu","year":"2017","journal-title":"Am J Clin Exp Urol"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27291_bib30","article-title":"Assessment of risk factors associated with fatty liver disease","volume":"17","author":"Xiang","year":"2009","journal-title":"World Chin. J. Dig."},{"key":"10.1016\/j.heliyon.2024.e27291_bib31","first-page":"648","article-title":"A 1\ufe301 matched case-control study on the risk factors of fatty liver in general people in guangdong province","volume":"35","author":"Ma","year":"2008","journal-title":"Mod. Prev. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000341","article-title":"Impact of weight loss on waist circumference and the components of the metabolic syndrome","volume":"5","author":"Rothberg","year":"2017","journal-title":"BMJ Open Diabetes Research & Care"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/oby.2003.35","article-title":"Relationship of neck circumference to cardiovascular risk factors","volume":"11","author":"Ben-Noun","year":"2003","journal-title":"Obes. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib34","article-title":"Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver disease","volume":"10","author":"Targher","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-015-0060-z","article-title":"Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men","volume":"12","author":"Li","year":"2015","journal-title":"Nutr. Metabol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27291_bib36","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.3390\/nu5104093","article-title":"Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD)","volume":"5","author":"Conlon","year":"2013","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2004.04.006","article-title":"Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease","volume":"8","author":"Choudhury","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2337\/diacare.27.3.824","article-title":"Definitions of the insulin resistance syndrome","volume":"27","author":"Bloomgarden","year":"2004","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27291_bib39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","article-title":"Non-alcoholic steatohepatitis in type 2 diabetes mellitus","volume":"19","author":"Gupte","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27291_bib40","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.heliyon.2024.e27291_bib41","first-page":"64","article-title":"The relationship between fatty liver and hyperlipidemia","volume":"6","author":"Lin","year":"2006","journal-title":"Mod. Hosp."},{"key":"10.1016\/j.heliyon.2024.e27291_bib42","unstructured":"Yu L NJ. New advances in nonalcoholic fatty liver research. Chin J Gerontol.2148-2151.."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27291_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1445-5994.2009.01979.x","article-title":"Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes","volume":"40","author":"Hwang","year":"2010","journal-title":"Intern. Med. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27291_bib44","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","article-title":"Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese","volume":"97","author":"Li","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27291_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00223-010-9347-2","article-title":"Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men","volume":"86","author":"Kim","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib46","first-page":"CR5","article-title":"Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes","volume":"15","author":"Yaturu","year":"2009","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27291_bib47","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/jbmr.13","article-title":"Men with metabolic syndrome have lower bone mineral density but lower fracture risk-the MINOS study","volume":"25","author":"Szulc","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1507\/endocrj.K10E-297","article-title":"Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women","volume":"58","author":"Jeon","year":"2011","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2011.04038.x","article-title":"Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease","volume":"75","author":"Pirgon","year":"2011","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12020-012-9613-3","article-title":"The role of pro\/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy","volume":"42","author":"Campos","year":"2012","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2036.2011.04924.x","article-title":"Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children","volume":"35","author":"Pardee","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","article-title":"Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women","volume":"42","author":"Moon","year":"2012","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2036.2012.05196.x","article-title":"Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27291_bib54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ajcn\/87.5.1374","article-title":"Pathways underlying iron accumulation in human nonalcoholic fatty liver disease","volume":"87","author":"Aigner","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27291_bib55","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1309\/6VJ4DWGYDU0XYJ8Q","article-title":"Correlation of serum TNF-\u03b1 levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease","volume":"127","author":"Manco","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"79","key":"10.1016\/j.heliyon.2024.e27291_bib56","first-page":"2099","article-title":"Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha","volume":"54","author":"Chu","year":"2007","journal-title":"Hepato-Gastroenterology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcb.1202","article-title":"Tumor necrosis factor-? mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism","volume":"83","author":"Zou","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27291_bib58","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00125-011-2155-z","article-title":"The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism","volume":"54","author":"Ducy","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4149\/endo_2011_02_99","article-title":"Osteocalcin is a stress-responsive neuropeptide","volume":"45","author":"Patterson-Buckendahl","year":"2011","journal-title":"Endocr. Regul."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27291_bib60","first-page":"114","article-title":"Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis","volume":"18","author":"Pietschmann","year":"1991","journal-title":"Acta Med. Austriaca"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27291_bib61","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/00365513.2011.604427","article-title":"Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration","volume":"71","author":"Yilmaz","year":"2011","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1373\/clinchem.2014.231753","article-title":"Neuromedin U: a multifunctional neuropeptide with pleiotropic roles","volume":"61","author":"Martinez","year":"2015","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27291_bib63","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm1640","article-title":"Central control of bone remodeling by neuromedin U","volume":"13","author":"Sato","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/ENDO:16:3:201","article-title":"Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem","volume":"16","author":"Niimi","year":"2001","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib65","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbrc.2003.10.098","article-title":"Central actions of neuromedin U via corticotropin-releasing hormone","volume":"311","author":"Hanada","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib66","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14728222.9.4.875","article-title":"Neuromedin U--a new target in obesity","volume":"9","author":"Doggrell","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1096\/fj.201901743R","article-title":"Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic \u03b2\u2010cells","volume":"34","author":"Zhang","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.heliyon.2024.e27291_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.713961","article-title":"Neuromedins NMU and NMS: an updated overview of their functions","volume":"12","author":"Malendowicz","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27291_bib69","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3803\/EnM.2022.1434","article-title":"The impact of insulin resistance on hepatic fibrosis among United States adults with non-alcoholic fatty liver disease: NHANES 2017 to 2018","volume":"37","author":"Bae","year":"2022","journal-title":"Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2020.05.040","article-title":"Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B","volume":"73","author":"Mak","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27291_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.09.044","article-title":"Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B","volume":"16","author":"Seto","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e27291_bib72","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.18.5.951","article-title":"Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets","author":"Kaczmarek","year":"2006","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27291_bib73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/psc.2727","article-title":"Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake","volume":"21","author":"Dalb\u00f8ge","year":"2015","journal-title":"J. Pept. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27291_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/psc.2582","article-title":"Development of a neuromedin U\u2013human serum albumin conjugate as a long\u2010acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide","volume":"20","author":"Neuner","year":"2013","journal-title":"J. Pept. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e27291_bib75","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/en.2010-1463","article-title":"Effects of peripherally administered neuromedin U on energy and glucose homeostasis","volume":"152","author":"Peier","year":"2011","journal-title":"Endocrinology"}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2025.e43172","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402403322X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402403322X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:46:45Z","timestamp":1769046405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402403322X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S240584402403322X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27291","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e27291"}}